Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transmembrane protein 186 | 1.000 | 0.077 | 5.2E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
ASXL transcriptional regulator 3 | 0.590 | 0.577 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
bromodomain PHD finger transcription factor | 0.560 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 | 0.579 | 0.731 | 1.5E-15 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
MAGE family member L2 | 0.560 | 0.654 | 0.98 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
phosphatidylinositol glycan anchor biosynthesis class G | 0.792 | 0.231 | 5.4E-15 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
VPS11 core subunit of CORVET and HOPS complexes | 0.633 | 0.654 | 1.9E-05 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
Ral GTPase activating protein non-catalytic subunit beta | 0.659 | 0.577 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
synthesis of cytochrome C oxidase 2 | 0.479 | 0.846 | 7.5E-07 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.434 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
SRY-box transcription factor 5 | 0.545 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
syntaxin binding protein 1 | 0.532 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
post-GPI attachment to proteins phospholipase 3 | 0.628 | 0.731 | 1.9E-03 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
OTU deubiquitinase 6B | 0.659 | 0.538 | 1.3E-07 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
potassium channel tetramerization domain containing 3 | 0.931 | 0.115 | 0.10 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
cystatin B | 0.530 | 0.692 | 6.6E-03 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
pogo transposable element derived with ZNF domain | 0.599 | 0.577 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
non-SMC condensin II complex subunit H2 | 0.805 | 0.385 | 2.9E-04 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
H3.3 histone A | 0.559 | 0.692 | 0.12 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
myosin binding protein C1 | 0.666 | 0.462 | 4.8E-05 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
retinoic acid receptor beta | 0.478 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0 | 2 |